Abstract
Glutamate is utilised as a transmitter in many pathways playing a key role in basal ganglia function i. e. the corticostriatal connections (Herrling, 1985) and the subthalamic nucleus efferents (Brotchie and Crossman, 1991a) to both pallidal segments and the substantia nigra pars reticulata.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albin, R.L., Young, A.B. and Penney, J.B., 1989, The functional anatomy of basal ganglia disorders, Trends Neurosci. 12: 366–375.
Bergman, H., Wichmann, T., Karmon, B. and DeLong, M.R., 1994, The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism, J Neurophysiol 72(2): 507–520.
Brotchie, J.M. and Crossman, A.R., 1991a, D-[3H]aspartate and [14C] GABA uptake in the basal ganglia of rats following lesions in the subthalamic region suggest a role for excitatory amino acid-but not GABA-mediated transmission in the subthalamic nucleus efferents, Exp. Neurol. 113: 171–181.
Brotchie, J.M., Mitchell, I.J., Sambrook, M.A. and Crossman, A.R., 1991b, Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate, Movement Disorders 6: 133–138.
Calabresi, P., Pisani, A., Mercuri, N.B. and Bernadi, G., 1996, The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia, Trends Neurosci. 19: 19–24.
Campbell, K. and Bjorklund, A., 1994, Prefrontal corticostriatal afferents maintain increased enkephalin gene expression in dopamine-denervated rat striatum, Eur. J. Neurosci. 6: 1371–1383.
Carroll, C.B., Holloway, V., Brotchie, J.M. and Mitchell, I.J., 1995, Neurochemical and behavioral investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms, Psychopharmacology 119(1): 55–65.
Chavkin, C., James, I.F. and Goldstein, A., 1982, Dynorphin is a specific endogenous ligand of the kappa opioid receptor, Science 215: 413–415.
Engber,.M., Susel, Z., Kuo, S., Gerfen, C.R. and Chase, T.N., 1991, Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxy-dopamine lesioned rats, Brain Res. 552: 113–118.
Gerfen, C.G. and Young III, W.S., 1988, Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridisation histochemistry and fluorescent retrograde tracing study, Brain Res. 460: 161–167
Girault, J-A., Horiuchi, A., Gustafson, E.L., Rosen, N.L. and Greengard, P., 1990, Differential expression of cAMP-regulated phosphoproteins, one of which is specifically associated with dopamine-innervated brain regions, J. Neurosci. 10(4): 1124–1133.
Haber, S.N., and Watson, S.J., 1983, The comparison between enkephalin-like and dynorphin-like immunore-activity in both monkey and human globus pallidus, Life Sci. Suppl. 33: 162–165.
Hazrati, L.N., Parent, A., Mitchell, S. and Haber, S.N., 1990, Evidence for interconnections between the two segments of the globus pallidus in primates: a PHA-L anterograde tracing study, Brain Res. 533(1): 171–175.
Hemmings, H.C., Jr., Walaas, S.I., Ouimet, C.C. and Greengard, P., 1987, Dopaminergic regulation of protein phosphorylation in the striatum: DARPP-32, Trends Neurosci. 10: 377–383.
Herrling, P.L., 1985, Pharmacology of the corticocaudate excitatory postsynaptic potential in the cat: evidence for its mediation by quisqualate-or kainate-receptors, Neuroscience 14: 417–426.
Hill, M.P. and Brotchie, J.B., 1995, Modulation of glutamate release by a K-opioid receptor agonist in rodent and primate striatum, Eur. J. Pharmacol. 281: R1–R2
Hughes, N.R., McKnight, A., Woodruff, G.N., Crossman, A.R. and Brotchie, J.M., Anti-parkinsonian effects of K-opioid receptor agonists in the reserpine-treated rat, Movement Disorders: in press.
Jiang, H.K., McGinty, J.F. and Hong, J.S., 1990, Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes, Brain Res. 507: 57–64.
Kincaid, A.E., Penney Jr., J.B. and Young, A.B., and Newman, S.W., 1991, Evidence for a projection from the globus pallidus to the entopeduncular nucleus in the rat, Neurosci. Lett. 128: 121–125.
Klockgether, T. and Turski, L., 1990, NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats, Ann. Neurol. 28(4): 539–546.
Lambert, P.D., Woodruff, G.N., Hughes, J. and Hunter, J.C., 1991, Inhibition of L-glutamate release: a possible mechanism of action for the neuroprotective effects of the kappa-selective agonist CI-977, Mol. Neuropharm. 1: 77–82.
Maneuf, Y.P., Mitchell, I.J., Crossman, A.R., Woodruff, G.N., and Brotchie, J.M., 1995, Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson’s disease, Brain Res. 683: 102–108.
Mansour, A., Fox, C. A., Akil, H., and Watson, S. J., 1995, Opioid receptor mRNA expression in the rat CNS: anatomical and functional implications, Trends Neurosci. 18: 22–29.
Miller, W.C., and DeLong, M.R., 1987, Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism, in: The Basal Ganglia, Volume II (M.A. Carpenter and A. Jarayaman, eds.), Plenum Press, New York, pp. 395–413.
Mitchell, I. J., Clark, C. E., Boyce, S., Robertson, S. G., Peggs, D., Sambrook, M. A., and Crossman, A. R., 1989, Neural mechanisms underlying Parkinsonian symptoms based upon regional uptake of 2-deoxy glucose in monkeys exposed to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine, Neuroscience 32: 213–226.
Mitchell, I.J., Hughes, N. Carroll, C.B., and Brotchie, J.M., 1995, Reversal of parkinsonian symptoms by intrastriatal and systemic manipulations of excitatory amino acid and dopamine transmission in the bilateral 6-OHDA lesioned marmoset, Behavioural Pharamacol. 6: 492–507.
Robertson, R.G., Farmery, S.M., Sambrook, M.A. and Crossman, A.R., 1989. Dyskinesia in the primate following injection of an excitatory amino acid antagonist into the medial segment of the globus pallidus, Brain Res. 476: 317–322.
Turski, L., Klockgether, T., Turski, W. A., Schwarz, M., and Sontag, K. H., 1990, Blockade of excitatory neurotransmission in the globus pallidus induces rigidity and akinesia in the rat: implications for excitatory neurotransmission in pathogenesis of Parkinson’s disease, Brain Res. 512(1): 125–131.
Vincent, S.R., Hokfelt, T., Christensson, I., and Terenius, L., 1982, Immunohistochemical evidence or a dynorphin immunoreactive striatonigral pathway, Eur. J. Pharmacol. 85: 251–252.
Wagner, J.J., Terman, G.W., and Chavkin, C. 1993, Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus, Nature 363: 451–454.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hill, M.P., Hille, C.J., Maneuf, Y.P., Brotchie, J.M. (1996). Modulation of Glutamate Transmission in the Rodent and Primate Basal Ganglia by the Selective Kappa-Opioid Receptor Agonist, Enadoline. In: Ohye, C., Kimura, M., McKenzie, J.S. (eds) The Basal Ganglia V. Advances in Behavioral Biology, vol 47. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0194-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0194-1_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0196-5
Online ISBN: 978-1-4899-0194-1
eBook Packages: Springer Book Archive